Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors
Source: SEC Form 13F · as of Mar 2026Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors holds 18 biotech & pharma companies tracked by BioSniper, totaling $26.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$26.2M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 5,000 | $4.6M |
| AMGNAMGEN INC | 12,799 | $4.5M |
| MRKMerck & Co., Inc. | 31,072 | $3.7M |
| JNJJOHNSON & JOHNSON | 14,821 | $3.6M |
| AZNASTRAZENECA PLC | 13,138 | $2.6M |
| ABBVAbbVie Inc. | 8,736 | $1.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,683 | $1.3M |
| ABTABBOTT LABORATORIES | 8,380 | $860K |
| PMPhilip Morris International Inc | 4,621 | $764K |
| GILDGILEAD SCIENCES, INC. | 3,988 | $556K |
| BMYBRISTOL MYERS SQUIBB CO | 7,285 | $442K |
| PFEPFIZER INC | 12,672 | $356K |
| GEHCGE HealthCare Technologies Inc. | 4,323 | $308K |
| MCKMcKesson Corporation | 297 | $257K |
| ELANElanco Animal Health Inc | 8,835 | $211K |
| IBRXImmunityBio, Inc. | 15,000 | $115K |
| SANASana Biotechnology, Inc. | 15,750 | $45K |
| NKTXNkarta, Inc. | 16,000 | $34K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.